MedPath

Brain Tumor Treatment Satisfaction Survey

Completed
Conditions
Brain Tumors
Registration Number
NCT00557375
Lead Sponsor
Methodist Healthcare
Brief Summary

Patients with recent diagnosis and treatment of a brain tumor will complete a short questionnaire concerning the patient's quality of life and emotional state since receiving treatment. Caregivers will complete a one-page questionnaire concerning the patient's quality of life and emotional state since receiving treatment.

Detailed Description

Patients with a recent diagnosis and treatment of a brain tumor (primary or metastatic; N=105, 61% female, 39% male) were identified in the clinics of Semmes-Murphey Neurologic and Spine Institute or the Methodist University Hospital in Memphis, TN. Caregivers were recruited from among relatives and friends who provide the most day-to-day care to the patient. All participants were between 3 months and 1 year from their most recent brain tumor treatment. Participants were given a simple, 5-point based survey to asses treatment-specific satisfaction, patient education, posttreatment quality of life, and pre- and post-treatment emotional impact. Therapeutic modalities surveyed include: surgery, external beam radiotherapy, whole-brain radiotherapy, stereotactic radiosurgery, and chemotherapy.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
105
Inclusion Criteria
  • Patients who are between 3 months and one year out from treatment for their brain tumor
  • Karnofsky Performance Status (KPS) >= 60
  • Age 18 years or over, any gender, any race
  • "patient caregivers will be individuals who provide the most day-to-day care for their respective brain tumor patients
Read More
Exclusion Criteria
  • No exclusions
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Overall satisfaction and emotional impact of treatments in patients who have undergone therapy(s)for brain tumors.(greater than or equal to 3 months) from first treatment for brain tumor
Secondary Outcome Measures
NameTimeMethod
Observational data about the treatment course and emotional well-being of the brain tumor patient as provided by the caregiver.(Greater than or equal to 3 months) from first treatment for brain tumor

Trial Locations

Locations (1)

Methodist University Hospital

🇺🇸

Memphis, Tennessee, United States

© Copyright 2025. All Rights Reserved by MedPath